Bvg Life Sciences Limited - Due diligence report

A 360° intelligence report on Bvg Life Sciences: trust score, financial health, credit view, compliance, directors, growth and distress sign…

2014-07-03 Pune, Maharashtra Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Bvg Life Sciences — 360° Intelligence Report

Generated from MCA filings & public records
65/100
Trust Score
Moderate

Bvg Life Sciences is assessed as Moderate with a Trust Score of 65/100. Bvg Life Sciences is an active public limited indian non-government company incorporated in 2014, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 16 Oct 2026 from the latest processed filings. Bvg Life Sciences Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
65/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
58/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (39.50 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Compliance Score: 58/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Flagged by authority: EPFO.
  • 3 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
GANESH SHRIPAD LIMAYE 01234567 Director 01/04/2018 6 yrs Approved
HANMANTRAO GAIKWAD 01234567 Director 01/04/2018 6 yrs Approved
VIKAS VYANKAT NIPANE 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
0 allotment(s) · 3 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Group entityRelationship% held
Bvg Innovations Private Limited Subsidiary Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 55
Growth signals & trust indicators
Operating for 12+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Negative net worth.
Compliance score is weak (58/100).
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence59/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment51/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 39.50 Lakh already registered.
  • Compliance gaps should be priced into terms.
Investor view46/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
27 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
23 Mar 2023
Director ceased
VIKAS VYANKAT NIPANE
Director ceased
PAWAN KUMAR SINGH
19 Mar 2022
Director ceased
UMESH GAUTAM MANE
02 Mar 2022
Director appointed
VIKAS VYANKAT NIPANE (Director)
31 Dec 2020
Charge created
Others - 39.50 Lakh
30 Sep 2019
Director ceased
GANESH SHRIPAD LIMAYE
31 Mar 2019
Share transfer (FY 2019)
2500.00000000 shares to H R Gaikwad Family Trust I
Share transfer (FY 2019)
2500.00000000 shares to H R GAIKWAD FAMILY TRUST II
Share transfer (FY 2019)
2500.00000000 shares to H R GAIKWAD FAMILY TRUST III
01 Mar 2019
Director appointed
GANESH SHRIPAD LIMAYE (Director)
Director ceased
VAISHALI HANMANTRAO GAIKWAD
03 Jul 2014
Incorporated
Registered with Roc Pune
Director appointed
HANMANTRAO GAIKWAD (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
3 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Metalloplast Private Limited U29100PN2018PTC179850 Pune, Maharashtra
GURUDEVA DEVCON LIMITED LIABILITY PARTNE RSHIP AAC-0441 Pune, Maharashtra
Krsnaa Retail Private Limited U86900PN2024PTC229841 Pune, Maharashtra
SSD LEGAL ALLIANCE LLP ACC-4493 Pune, Maharashtra
Gurulaxmi Auto Engineering Private Limited U29299PN2010PTC137269 Pune, Maharashtra
Virgo Composites Private Limited U34300PN2011PTC138883 Pune, Maharashtra
3St Manufacturing Solutions Private Limited U34100PN2016PTC165956 Pune, Maharashtra
Ganesha Engisol Private Limited U29100PN2020PTC189939 Pune, Maharashtra
Ravikas Automotive Systems Private Limited U34300PN2018PTC175792 Pune, Maharashtra
Ozar Marines And Innovation Private Limited U31900PN2019PTC185698 Pune, Maharashtra
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Bvg Life Sciences before audits and certifications: compliance score 58/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Bvg Life Sciences: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Bvg Life Sciences - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 65/100, distress signals and MSME payment-delay disclosures - know whether Bvg Life Sciences pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Bvg Life Sciences - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Bvg Life Sciences an active company?

Bvg Life Sciences has MCA status “Active” with a compliance score of 58/100 (Moderate).

Is Bvg Life Sciences financially healthy?

Bvg Life Sciences has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Bvg Life Sciences?

Its overall Trust Score is 65/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Bvg Life Sciences?

Promoters hold a majority stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Bvg Life Sciences have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Bvg Life Sciences up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 58/100 (Moderate).

Is it risky to lend to Bvg Life Sciences?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.